Fibroblastic reticular cells power immune defenses in lung cancer

Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, clustering, and activation. This study highlights FRCs’ potential as therapeutic targets to boost anti-tumor immunity in non-small cell lung cancer (NSCLC).

Modern Health Acquires Anvil Health’s AI Technology to Enhance Mental Healthcare

What You Should Know: – Modern Health, a global workplace mental health platform, announced today the acquisition of Anvil Health’s AI technology and the appointment

August 9, 2024

New dose schedule for J&J bispecific; Layoffs at Ring Therapeutics; Regeneron’s priority review

Plus, news about Enveric Biosciences and Kazia Therapeutics: Johnson & Johnson’s bispecific gets a new dosing schedule: The FDA approved a reduced dosing regimen for

February 22, 2024

New study links prenatal chemical exposure to childhood obesity trajectories

Connections between prenatal exposure to endocrine-disrupting chemicals and the growth patterns of children’s BMI.

October 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.